Clinical Trial Update: Supportive Measures in Treatment of Aluminum Phosphide Poisoning [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing prognostic factors and the role of N-acetylcysteine with supportive care in aluminum phosphide poisoning.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aluminum Phosphide Poisoning

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Assiut University | Conditions: Detection of Different Prognostic Factors and Their Relation With the Outcome, Using New Protocol to Prove the Role of N-acetyl Cysteine and Adequate Supportive Measures in Aluminum Phosphide Poisoning | Phase 4 | Status: COMPLETED